PNEUMO-MED s.r.o.
- Address
- Nabrezna 5, 971 01 Prievidza, Slovakia
PNEUMO-MED s.r.o. - Respiratory Medicine Research Center
PNEUMO-MED s.r.o. is a specialized respiratory medicine research facility focused on advancing treatments for challenging pulmonary conditions. The center demonstrates particular expertise in investigating novel therapeutic approaches for chronic respiratory disorders that remain difficult to manage with conventional treatments.
- Refractory and unexplained chronic cough disorders
- Phase 3 clinical trials evaluating innovative cough suppression therapies
- Advanced cough frequency monitoring and assessment methodologies
The facility is actively engaged in cutting-edge research examining refractory chronic cough (RCC), including cases of unexplained chronic cough that significantly impact patient quality of life. Through rigorous 24-week randomized controlled trials with open-label extensions, PNEUMO-MED s.r.o. contributes to understanding both efficacy and safety profiles of emerging pharmacological agents designed to address this debilitating condition in adult patients who have exhausted standard treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in PNEUMO-MED s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized Double-Blind Study of Camlipixant (BLU-5937) Versus Placebo in Adults with Refractory or Unexplained Chronic Cough | Bellus Health Inc. | Phase III | Not Recruiting | Mar 2023 | Jul 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Camlipixant | 1 | Unknown | 2023-03-30 | 2023-03-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.